Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A common stock, $0.0001 par value per share
-
Shares outstanding
-
94,391,904
-
Total 13F shares
-
70,585,119
-
Share change
-
-797,680
-
Total reported value
-
$5,525,384,396
-
Put/Call ratio
-
59%
-
Price per share
-
$78.28
-
Number of holders
-
215
-
Value change
-
-$102,099,624
-
Number of buys
-
129
-
Number of sells
-
75
Institutional Holders of Nuvalent, Inc. - Class A common stock, $0.0001 par value per share (NUVL) as of Q4 2024
As of 31 Dec 2024,
Nuvalent, Inc. - Class A common stock, $0.0001 par value per share (NUVL) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,585,119 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FMR LLC, Paradigm Biocapital Advisors LP, VANGUARD GROUP INC, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, COMMODORE CAPITAL LP, STATE STREET CORP, Bain Capital Life Sciences Investors, LLC, and Fairmount Funds Management LLC.
This page lists
215
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.